Discuss the latest strategies to harness the immune system for the development of innovative therapeutics
Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.
This event is co-located with our well established 6th Annual Biomarkers & Precision Medicine USA Congress.
The established event provides an additional 45+ presentations on biomarker research, with key focusses on biomarkers for
translational science, clinical development and targeted therapies.
The 2022 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
The following are confirmed speakers for the 2022 event.
Book now to take advantage of early registration rates.
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.